文献速递类风湿关节炎

高敏心肌肌钙蛋白I是类风湿关节炎患者隐匿性冠状动脉斑块负荷和心血管事件的生物标志物

High-sensitivity cardiac troponin I is a biomarker for occult coronary plaque burden and cardiovascular events in patients with rheumatoid arthritis.
PubMed 文献 · Rheumatology (Oxford) · 2018-01-01

研究纳入150例类风湿关节炎患者,行64层冠状动脉CT血管造影评估斑块负荷并检测血浆高敏心肌肌钙蛋白I(hs-cTnI)与促炎细胞因子,随访60(标准差26)个月。结果显示血浆hs-cTnI与所有冠状动脉斑块结局相关(P<0.01),升高(≥1.5 pg/ml)独立预测全部心血管事件风险(P=0.03),低hs-cTnI预示广泛动脉粥样硬化和心血管事件风险较低。

要点

  • 血浆hs-cTnI与所有冠状动脉斑块结局相关(P<0.01)。
  • hs-cTnI≥1.5 pg/ml与显著钙化、广泛动脉粥样硬化、阻塞性斑块及任何晚期混合或钙化斑块相关(均P<0.05)。
  • 升高hs-cTnI独立预测全部心血管事件风险(P=0.03),低hs-cTnI预示广泛动脉粥样硬化(P<0.05)和心血管事件(P=0.037)风险较低。

核心结论

  • 血浆hs-cTnI独立关联类风湿关节炎患者隐匿性冠状动脉斑块负荷、成分及长期新发心血管事件。
  • 低hs-cTnI预示广泛动脉粥样硬化和心血管事件风险均较低。
  • hs-cTnI可能因此优化类风湿关节炎的心血管风险分层。

研究设计与样本

  • 评估150例类风湿关节炎患者,行64层冠状动脉CT血管造影,评估冠状动脉钙化、斑块节段数(节段受累评分)、狭窄严重程度和斑块负荷。
  • 病变描述为非钙化、混合或完全钙化,冠状动脉CT血管造影期间检测血浆hs-cTnI和促炎细胞因子水平。
  • 受试者随访60(标准差26)个月,观察缺血性(心源性死亡、非致死性心肌梗死、卒中、外周动脉缺血)和非缺血性(新发心力衰竭住院)心血管事件。

主要发现

  • 血浆hs-cTnI与所有冠状动脉斑块结局相关(P<0.01)。
  • 校正心脏危险因素或Framingham D'Agostino评分后,hs-cTnI≥1.5 pg/ml与显著钙化、广泛动脉粥样硬化、阻塞性斑块及任何晚期混合或钙化斑块相关(均P<0.05)。
  • 11例患者发生心血管事件(1.54/100患者年),其中8例缺血性、3例非缺血性。
  • 升高hs-cTnI独立于人口学特征、心脏危险因素和泼尼松使用预测全部心血管事件风险(P=0.03)。
  • 低hs-cTnI预示广泛动脉粥样硬化(P<0.05)和新发心血管事件(P=0.037)风险较低。

关键数值与推荐

  • hs-cTnI升高定义为≥1.5 pg/ml,该阈值与显著钙化、广泛动脉粥样硬化、阻塞性斑块及任何晚期混合或钙化斑块相关(均P<0.05)。
  • 心血管事件发生率1.54/100患者年,11例事件中8例缺血性、3例非缺血性。

临床怎么用

  • 原文结论指出hs-cTnI可能优化类风湿关节炎的心血管风险分层(作者认为)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Patients with RA display greater occult coronary atherosclerosis burden and experience higher cardiovascular morbidity and mortality compared with controls. We here explored whether pro-inflammatory cytokines and high-sensitivity cardiac troponin I (hs-cTnI), a biomarker of myocardial injury, correlated with plaque burden and cardiovascular events (CVEs) in RA. METHODS: We evaluated 150 patients with 64-slice coronary CT angiography. Coronary artery calcium, number of segments with plaque (segment involvement score), stenotic severity and plaque burden were assessed. Lesions were described as non-calcified, mixed or fully calcified. Blood levels of hs-cTnI and pro-inflammatory cytokines were assessed during coronary CT angiography. Subjects were followed over 60 (s.d. 26) months for both ischaemic [cardiac death, non-fatal myocardial infarction (MI), stroke, peripheral arterial ischaemia] and non-ischaemic (new-onset heart failure hospitalization) CVEs. RESULTS: Plasma hs-cTnI correlated with all coronary plaque outcomes (P < 0.01). Elevated hs-cTnI (⩾1.5 pg/ml) further associated with significant calcification, extensive atherosclerosis, obstructive plaque and any advanced mixed or calcified plaques after adjustments for cardiac risk factors or Framingham D'Agostino scores (all P < 0.05). Eleven patients suffered a CVE (1.54/100 patient-years), eight ischaemic and three non-ischaemic. Elevated hs-cTnI predicted all CVE risk independent of demographics, cardiac risk factors and prednisone use (P = 0.03). Conversely, low hs-cTnI presaged a lower risk for both extensive atherosclerosis (P < 0.05) and incident CVEs (P = 0.037). CONCLUSION: Plasma hs-cTnI independently associated with occult coronary plaque burden, composition and long-term incident CVEs in patients with RA. Low hs-cTnI forecasted a lower risk for both extensive atherosclerosis as well as CVEs. hs-cTnI may therefore optimize cardiovascular risk stratification in RA.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Karpouzas GA, Estis J, Rezaeian P, et al. High-sensitivity cardiac troponin I is a biomarker for occult coronary plaque burden and cardiovascular events in patients with rheumatoid arthritis. Rheumatology (Oxford). 2018. PMID: 29554376. doi:10.1093/rheumatology/key057

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。